Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Bittner

Showing results (41-50 of 240) with videos related to

Pageof 24
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2010
Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosisSven G Meuth, Stefan Bittner, Carola Seiler, et al.
Pflugers Archiv : European Journal of Physiology|December 9, 2014
The CNS under pathophysiologic attack--examining the role of K₂p channelsPetra Ehling, Manuela Cerina, Thomas Budde, et al.
Optics Letters|December 15, 2025
Polarization and transverse-mode nonlinear dynamics in a multimode VCSELYohann G Sanvert, Jules Mercadier, Stefan Bittner, et al.
Neuroscience Letters|December 1, 2021
Mini-Review: Two Brothers in Crime - The Interplay of TRESK and TREK in Human DiseasesNiklas Huntemann, Stefan Bittner, Stefanie Bock, et al.
Deutsches Arzteblatt International|June 17, 2025
Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory DiseasesStefan Bittner, Martin A. Kriegel, Britta Siegmund, et al.
Rheumatology (Oxford, England)|January 2, 2015
Long-term efficacy of alemtuzumab in polymyositisTobias Ruck, Stefan Bittner, Tanja Kuhlmann, et al.
Journal of Immunological Methods|October 8, 2020
Intracellular fluoride influences TASK mediated currents in human T cellsAlexander M Herrmann, Manuela Cerina, Stefan Bittner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2011
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetesJulie Joseph, Stefan Bittner, Fabian M P Kaiser, et al.
Ebiomedicine|December 19, 2022
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisMuriel Schraad, Timo Uphaus, Stefan Runkel, et al.
Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.
Pageof 24

Showing results (41-50 of 240) with videos related to

Sort By:
Pageof 24
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2010
Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosisSven G Meuth, Stefan Bittner, Carola Seiler, et al.
Pflugers Archiv : European Journal of Physiology|December 9, 2014
The CNS under pathophysiologic attack--examining the role of K₂p channelsPetra Ehling, Manuela Cerina, Thomas Budde, et al.
Optics Letters|December 15, 2025
Polarization and transverse-mode nonlinear dynamics in a multimode VCSELYohann G Sanvert, Jules Mercadier, Stefan Bittner, et al.
Neuroscience Letters|December 1, 2021
Mini-Review: Two Brothers in Crime - The Interplay of TRESK and TREK in Human DiseasesNiklas Huntemann, Stefan Bittner, Stefanie Bock, et al.
Deutsches Arzteblatt International|June 17, 2025
Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory DiseasesStefan Bittner, Martin A. Kriegel, Britta Siegmund, et al.
Rheumatology (Oxford, England)|January 2, 2015
Long-term efficacy of alemtuzumab in polymyositisTobias Ruck, Stefan Bittner, Tanja Kuhlmann, et al.
Journal of Immunological Methods|October 8, 2020
Intracellular fluoride influences TASK mediated currents in human T cellsAlexander M Herrmann, Manuela Cerina, Stefan Bittner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2011
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetesJulie Joseph, Stefan Bittner, Fabian M P Kaiser, et al.
Ebiomedicine|December 19, 2022
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisMuriel Schraad, Timo Uphaus, Stefan Runkel, et al.
Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.
Pageof 24